Drug Profile
CELEXT 07
Alternative Names: CELENT-07; CELENXT-07; CELEXT-07Latest Information Update: 10 Nov 2021
Price :
$50
*
At a glance
- Originator 9305-9954 Quebec
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Onychomycosis
Most Recent Events
- 14 Oct 2021 Discontinued - Phase-II for Onychomycosis in Canada (Topical)
- 01 Aug 2016 Phase-II clinical trials in Onychomycosis in Canada (Topical) (NCT02644551)
- 29 Dec 2015 9305-9954 Quebec Inc plans a phase II trial for Onychomycosis in Canada (NCT02644551)